Truist Securities Maintains Buy on HCA Healthcare, Raises Price Target to $340
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst David Macdonald maintains a Buy rating on HCA Healthcare (NYSE:HCA) and raises the price target from $325 to $340.
June 20, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on HCA Healthcare and raises the price target from $325 to $340.
The raised price target by Truist Securities analyst David Macdonald indicates a positive outlook for HCA Healthcare. This news is likely to have a positive short-term impact on HCA's stock price as it suggests that the analyst believes the stock is undervalued and has potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100